Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3700 3736 3791
This examiner grants 65% of resolved cases
Devin B. Henson is an examiner in Art Unit 3700, part of Tech Center 3700. He has managed 805 resolved cases, providing a robust data set for analysis. His allowance rate is 65.0 percent, which is a solid indicator of a fair examination process. This 65.0 percent rate suggests that about two-thirds of the applications he reviews result in a granted patent, provided the claims are well-supported. The 805 resolved cases establish a reliable baseline for predicting outcomes in Art Unit 3700.
The interview lift for this examiner is 43.6 percent. This is an exceptionally high lift, suggesting that interviews are one of the most effective tools available to practitioners. The 43.6 percent increase over the baseline allowance rate of 65.0 percent implies that verbal advocacy is highly persuasive or helpful in his decision-making process. Applicants should prioritize interviews as a central part of their strategy to maximize their chances of success in Tech Center 3700.
The median days to allowance for his cases is 1343. This timeline is a bit longer than average, indicating that prosecution in Art Unit 3700 can be a deliberate process. Applicants should be prepared for a pendency of 1343 days. Despite the 1343-day median, the 65.0 percent allowance rate and the 43.6 percent interview lift provide a clear path forward for those willing to invest the necessary time and effort. The 1343-day duration is a critical factor for long-term planning.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18885869 | SYSTEMS AND METHODS FOR NON-CONTACT RESPIRATORY MONITORING | Non-Final OA | Covidien LP |
| 19036664 | DEVICES AND METHODS FOR TREATING A STRICTURE ALONG THE BILIARY AND/OR PANCREATIC TRACT | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18079919 | STEERABLE MEDICAL DEVICES | Non-Final OA | Boston Scientific Medical Device Limited |
| 18947526 | Joint Evaluation And Balancing | Non-Final OA | Howmedica Osteonics Corp. |
| 18813683 | ANALYTE MONITORING SYSTEMS AND METHODS FOR MONITORING MULTIPLE ANALYTES | Non-Final OA | Abbott Diabetes Care Inc. |
| 18744208 | ANALYTE MONITORING DEVICES HAVING A STRAIN GAUGE | Final Rejection | Abbott Diabetes Care Inc. |
| 18912303 | GUIDE WIRE TIP HAVING ROUGHENED SURFACE | Non-Final OA | Abbott Cardiovascular Systems Inc. |
| 19022813 | AUGMENTED AND VIRTUAL REALITY EYEWEAR, SYSTEMS, AND METHODS FOR DELIVERING POLARIZED LIGHT AND DETERMINING GLUCOSE LEVELS | Non-Final OA | Magic Leap, Inc. |
| 18567402 | DETERMINING SPECULAR REFLECTION INFORMATION | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18169646 | ASPIRATION ENDOSCOPE DEVICE AND METHODS OF USE THEREOF | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18812459 | Normalization and Calibration for Devices and Systems for Measuring Peripheral Hemodynamics | Non-Final OA | Washington University |
| 18507676 | DEVICES, SYSTEMS, METHODS AND COMPUTER-ACCESSIBLE MEDIUM FOR PROVIDING WIRELESS STENT-BASED INTERFACES TO THE NERVOUS SYSTEM | Final Rejection | Massachusetts Institute of Technology |
| 19022138 | BLOOD PRESSURE MEASUREMENT | Non-Final OA | Nokia Technologies Oy |
| 18695031 | WEARABLE DEVICE | Non-Final OA | GOERTEK INC. |
| 18627759 | SYSTEM AND METHODS FOR PERSONALIZED NON-ENZYME SIGNAL COMPENSATION | Final Rejection | Dexcom, Inc. |
| 17635507 | Sensor Assembly | Non-Final OA | Sanofi |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy